INCOME STATEMENT (Quarterly GAAP In millions $) |
(Sep 30 2021) III. Quarter |
(Jun 30 2021) II. Quarter |
(Mar 31 2021) I. Quarter |
(Dec 31 2020) IV. Quarter |
(Sep 30 2020) III. Quarter |
Revenue from Related Parties |
0.11 |
8.04 |
8.74 |
|
9.86 |
Sales Revenue, Goods, Gross |
0.11 |
14.84 |
8.74 |
|
10.36 |
Revenue From Contract With Customer Including Assessed Tax |
- |
- |
- |
|
- |
Revenues from Other Parties |
- |
6.80 |
0.00 |
|
0.50 |
Other Revenue |
-0.11 |
-14.84 |
-8.74 |
|
-10.36 |
Total Revenue |
0.11 |
14.84 |
8.74 |
5.36 |
10.36 |
Cost of Revenues |
0.95 |
15.07 |
7.78 |
5.09 |
8.83 |
Gross
Profit |
-0.84 |
-0.23 |
0.96 |
0.27 |
1.53 |
Selling, Administration, Marketing |
0.21 |
0.21 |
0.27 |
0.27 |
0.20 |
Depriciation & Amortization |
- |
- |
- |
- |
- |
Research & development |
- |
- |
- |
- |
- |
Restructuring, Accretion & impairment charges |
- |
- |
- |
- |
- |
Other operatinig exp. /-income |
-0.44 |
-8.14 |
-2.28 |
-0.06 |
-0.17 |
Unusual Expense /-Income |
- |
- |
- |
- |
- |
Related Parties Amount In Cost Of Sales |
0.95 |
8.14 |
- |
- |
- |
Total operating costs including COS |
1.67 |
15.27 |
5.77 |
5.30 |
8.86 |
Operating income/-loss
|
-1.56 |
-0.43 |
2.97 |
0.06 |
1.49 |
Other Deductions / - Income |
Interest expense |
- |
- |
- |
- |
- |
Interest Expense, Other |
0.13 |
-0.14 |
-0.13 |
0.12 |
0.13 |
Interest income |
- |
- |
- |
- |
- |
Net interest expense/-income |
0.13 |
0.14 |
0.13 |
0.12 |
0.13 |
Other Nonoperating Gains (Losses) |
- |
- |
- |
- |
- |
Foreign Currency Transaction Gain (Loss), Unrealized |
-0.09 |
-0.12 |
0.03 |
0.33 |
0.37 |
Allowances, Health Care Trust Fund And Other |
- |
- |
- |
- |
- |
Unexpected (Gain) Loss |
- |
- |
- |
- |
- |
Other loss/ -income |
-0.04 |
0.10 |
-0.10 |
0.03 |
-0.03 |
Total costs & expenses |
1.67 |
15.39 |
5.83 |
5.78 |
9.33 |
Income /-loss before income taxes |
-1.56 |
-0.55 |
2.91 |
-0.42 |
1.02 |
Income taxes expenses/-benefit |
- |
0.00 |
- |
0.00 |
0.03 |
Income after income taxes |
-1.56 |
-0.55 |
2.91 |
-0.42 |
1.00 |
Net income/-loss
of other equity |
- |
- |
- |
- |
- |
Income/-loss
from cont. Ops. |
-1.56 |
-0.55 |
2.91 |
-0.42 |
1.00 |
Accounting change |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Extraordinary items |
- |
- |
- |
- |
- |
Net Income/-loss |
-1.56 |
-0.55 |
2.91 |
-0.42 |
1.00 |
Noncontrolling interests |
-0.01 |
0.00 |
-0.01 |
- |
- |
Prefered dividends |
- |
- |
- |
- |
- |
Other |
- |
- |
- |
- |
- |
Income/-loss to shareholder |
-1.55 |
-0.54 |
2.92 |
-0.42 |
1.00 |
EBIT |
-1.43 |
-0.41 |
3.04 |
-0.30 |
1.15 |
EBITD |
-1.41 |
-0.39 |
3.05 |
-0.28 |
1.17 |
EBITDA |
-1.41 |
-0.39 |
3.05 |
-0.28 |
1.17 |